Kyle Mikson
Stock Analyst at Canaccord Genuity
(1.21)
# 3,554
Out of 4,884 analysts
89
Total ratings
33.78%
Success rate
-12.75%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Hold | $87 → $99 | $100.80 | -1.79% | 11 | Jun 11, 2025 | |
| AKYA Akoya Biosciences | Maintains: Hold | $1.8 → $1.08 | $1.36 | -20.59% | 5 | May 19, 2025 | |
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $46.72 | -7.96% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $2.5 → $1.5 | $0.27 | +452.28% | 4 | May 14, 2025 | |
| XGN Exagen | Maintains: Buy | $7 → $8 | $7.05 | +13.48% | 3 | May 13, 2025 | |
| QTRX Quanterix | Maintains: Buy | $15 → $12 | $6.98 | +71.92% | 6 | May 13, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $13.01 | +15.30% | 8 | May 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $42 → $37 | $20.30 | +82.27% | 4 | May 6, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $50.50 | +28.71% | 7 | May 1, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $127.47 | +17.67% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.60 | +87.50% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $161.76 | +20.55% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.03 | +191.26% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.5 → $1 | $2.14 | -53.27% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $53.36 | +40.55% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.74 | +170.27% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.60 | +8,139.83% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.76 | +405.32% | 1 | Jan 29, 2021 |
Illumina
Jun 11, 2025
Maintains: Hold
Price Target: $87 → $99
Current: $100.80
Upside: -1.79%
Akoya Biosciences
May 19, 2025
Maintains: Hold
Price Target: $1.8 → $1.08
Current: $1.36
Upside: -20.59%
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $46.72
Upside: -7.96%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.27
Upside: +452.28%
Exagen
May 13, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $7.05
Upside: +13.48%
Quanterix
May 13, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $6.98
Upside: +71.92%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $13.01
Upside: +15.30%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $42 → $37
Current: $20.30
Upside: +82.27%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $50.50
Upside: +28.71%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $127.47
Upside: +17.67%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.60
Upside: +87.50%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $161.76
Upside: +20.55%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $2.14
Upside: -53.27%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $53.36
Upside: +40.55%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.74
Upside: +170.27%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.60
Upside: +8,139.83%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.76
Upside: +405.32%